Home
Platform
Services
Brands
Locations
Careers
News
Library
Responsibility
Contact Us
Platform
Our Platform
Our Competitive Edge
Services
Preclinical Development
Clinical Development
Regulatory Affairs & Consulting
Data Sciences
Molecular Laboratory R&D Services
Microbiology and Diagnostics R&D Services
Brands
Clinglobal
About us
Our Services
Our Team
Clinvet
About us
Our Services
Our Team
Clindata
About us
Our Services
Our Team
Clinomics
About us
Our Services
Our Team
Clinaxel
Rtilab
Locations
Careers
News
Social Media
Library
Research Models
Publications
Responsibility
Our Purpose
Our Values
Corporate Responsibility
Compliance
Contact us
Immediate and persistent efficacy of sarolaner (Simparica™) against Haemaphysalis elliptica on dogs
Home
Immediate and persistent efficacy of sarolaner (Simparica™) against Haemaphysalis elliptica on dogs
digitalplatforms
April 24, 2025
0 Comments
File Type:
pdf
File Size:
714 KB
Categories:
Publications
Post navigation
Previous
Immediate and long-term efficacy of Felpreva®, a new spot-on formulation containing tigolaner, emodepside and praziquantel, applied as a single application to cats artificially infested with
Next
Immunity against Babesia rossi infection in dogs vaccinated with antigens from culture supernatants
